Recombinant multi-species CCT3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCT3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a molecular chaperone that is a member of the chaperonin containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Alternate transcriptional splice variants have been characterized for this gene. In addition, a pseudogene of this gene has been found on chromosome 8. [provided by RefSeq, Aug 2010]
The Alternative Names of target: CCT-gamma,CCT3,CCTG,Cct3,Cctg,Chaperonin containing T-complex polypeptide 1 subunit 3,PIG48,T-complex protein 1 subunit gamma,TCP-1-gamma,TRIC5,Tcp1-rs3,TriC-P5,hTRiC5
Go
to CCT3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP2418-Ag-1/ GM-Tg-hg-IP2418-Ag-2 | Human CCT3 protein | Human |
| GM-Tg-rg-IP2418-Ag-1/ GM-Tg-rg-IP2418-Ag-2 | Rat CCT3 protein | Rat |
| GM-Tg-mg-IP2418-Ag-1/ GM-Tg-mg-IP2418-Ag-2 | Mouse CCT3 protein | Mouse |
| GM-Tg-cynog-IP2418-Ag-1/ GM-Tg-cynog-IP2418-Ag-2 | Cynomolgus/Rhesus macaque CCT3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP2418-Ag-1/ GM-Tg-felg-IP2418-Ag-2 | Feline CCT3 protein | Feline |
| GM-Tg-cang-IP2418-Ag-1/ GM-Tg-cang-IP2418-Ag-2 | Canine CCT3 protein | Canine |
| GM-Tg-bovg-IP2418-Ag-1/ GM-Tg-bovg-IP2418-Ag-2 | Bovine CCT3 protein | Bovine |
| GM-Tg-equg-IP2418-Ag-1/ GM-Tg-equg-IP2418-Ag-2 | Equine CCT3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP2418-Ag-1/ GM-Tg-hg-IP2418-Ag-2;
GM-Tg-rg-IP2418-Ag-1/ GM-Tg-rg-IP2418-Ag-2;
GM-Tg-mg-IP2418-Ag-1/ GM-Tg-mg-IP2418-Ag-2; GM-Tg-cynog-IP2418-Ag-1/ GM-Tg-cynog-IP2418-Ag-2; GM-Tg-felg-IP2418-Ag-1/ GM-Tg-felg-IP2418-Ag-2; GM-Tg-cang-IP2418-Ag-1/ GM-Tg-cang-IP2418-Ag-2; GM-Tg-bovg-IP2418-Ag-1/ GM-Tg-bovg-IP2418-Ag-2; GM-Tg-equg-IP2418-Ag-1/ GM-Tg-equg-IP2418-Ag-2 |
| Products Name | CCT3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CCT3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCT3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.